- Home
- NEO vs SCZM Comparison
NEO vs SCZM Comparison
Compare NEO & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEO | SCZM |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Precision Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEO | SCZM |
|---|---|---|
| Price | $8.40 | $8.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $13.38 | $12.00 |
| AVG Volume (30 Days) | ★ 2.1M | 413.2K |
| Earning Date | 04-28-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | $79.38 |
| Revenue Next Year | $9.73 | N/A |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $6.90 |
| 52 Week High | $13.74 | $17.65 |
Technical Indicators
Market Signals| Indicator | NEO | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 47.09 |
| Support Level | $7.50 | $7.17 |
| Resistance Level | $8.84 | $9.05 |
| Average True Range (ATR) | 0.55 | 0.58 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 10.44 | 38.09 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About SCZM Santacruz Silver Mining Ltd. Common Shares
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.